title: Appropriate premedication risk reduction during adrenal ablation.
authors.forename: Deepak
authors.initials: D
authors.lastname: Sudheendra
authors.forename: Bradford J
authors.initials: BJ
authors.lastname: Wood
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003452:Cryosurgery / Q000009:adverse effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006974:Hypertension, Malignant / Q000209:etiology / Q000517:prevention & control*; D010643:Phenoxybenzamine / Q000627:therapeutic use; D015641:Radiography, Interventional; D018570:Risk Assessment; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D019805:alpha-Methyltyrosine / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D010643:Phenoxybenzamine; D019805:alpha-Methyltyrosine; D014446:Tyrosine 3-Monooxygenase